Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BUCY vs TBICY Conditioning for Standard-risk ALL
NCT02670252Phase 3Completed
- Sponsor
- Nanfang Hospital, Southern Medical University
- Start
- Jan 2016
- Primary completion
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of busulfan in acute lymphoblastic leukemia (ALL), sponsored by Nanfang Hospital, Southern Medical University. Started Jan 2016; status: completed.
02
Drugs
busulfan
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT02670252.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02670252.